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(Andersen 2013, from Spencer et al. Br J Nutr 2008, Jenab et al. Hum Genet 2009, Manach et al. Mol Nutr Food Res 2009)
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(Nicholson et al. Nature, 2010; Patti et al. Nat Rev Mol Cell Biol, 2012)
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(Bouatra, …, Wishart. The human urine metabolome. Plos One, 2013; Wishart et al. Nucleic Acids Res, 2013; Scalbert et al. Am J Clin Nutr, 2014)



























Tissue & Microbial 
Biotransformations
(Bouatra, …, Wishart. The human urine metabolome. Plos One, 2013; Wishart et al. Nucleic Acids Res, 2013; Scalbert et al. Am J Clin Nutr, 2014)






 Segmentation of poor or high 
absorbers & metabolizers







 New potential food bioactives
Analysis of food metabolome
(Manach, Glasgow 2013; Scalbert et al. Am J Clin Nutr, 2014)
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(Llorach R et al. J Agric Food Chem, 2012; Pujos-Guillot et al. J Proteome Res, 2013)
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(Scalbert et al. Am J Clin Nutr, 2014;99(6):1286-1308)
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(Llorach R et al. J Agric Food Chem, 2012; Scalbert et al. Am J Clin Nutr, 2014)
Distribution of compounds into various foods
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Crit Rev Food Sci Nutr, 2014
Sanguiin H6
(Llorach R et al. J Agric Food Chem, 2012; Scalbert et al. Am J Clin Nutr, 2014)
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Identify biomarkers related to the intake of certain foods (markers
of consumption) and its possible association with health (markers
of effect) by the application of an HPLC-QToF-MS nontargeted
metabolomic strategy in nutritional studies with different designs .
Since metabolomics offers a new approach for the determination of
biomarkers of dietary exposure, we will observe differences in meta-
bolic fingerprints associated with the consumption of food, which will
allow us to predict its intake.
Introduction Methodology Results ConclusionsObjectives
Characterize urinary metabolic fingerprint associated with the intake
of widely consumed foods: bread, nuts, cocoa.
Replicate characterized biomarkers of exposure in controlled clinical
trials in a free-living population.
Develop predictive models for determining usual intake and compare
its predictive ability with respect to the ability of the metabolites
evaluated individually.
























































(Llorach-Asuncion et al. J Pharm Biomed Anal, 2010)
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(Llorach-Asuncion et al. J Pharm Biomed Anal, 2010; Fernández-Albert et al. Anal Chem, 2014)
COELUTION & CORRELATION
Mass spectrum
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Quality control
• QC1: Milli-Q water
• QC2: pool of phenolic compounds
• QC3: pool of endogenous compounds





Unsupervised & supervised techniques (PCA; PLS-DA)
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Data 
Acquisition
Marker detection & Alignment
Visualization of results from metabolome
(Llorach-Asuncion et al. J Pharm Biomed Anal, 2010)
(Garcia-Aloy M et al. J Protome Res, 2014; Garcia-Aloy M et al. Metabolomics, 2015; Semba et al. Andres-Lacueva JAMA Intern Med, 2014; Urpi-Sarda et al. Mol Nutr Food Res, 2014;
Llorach et al. Mol Nutr Food Res, 2013; Tulipani et al. Anal Chem, 2013; Tulipani et al. J Proteome Res, 2011; Llorach et al. J Pharm Biomed Anal, 2010; Fernandez-Albert et al. Anal

































Identified compounds Comparison of ≥2 orthogonal properties with an authentic 




Based upon property similarity with public/commercial 




Based upon properties of known compounds of a chemical class.
4
Unknown compounds Unidentified compounds.
(Sumner et al. Proposed minimum reporting standards for chemical analysis (CAWG-MSI). Metabolomics, 2007)














(Llorach R et al. J Agric Food Chem, 2012; Scalbert et al. Am J Clin Nutr, 2014)
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Distribution of compounds into various foods
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(Xia et al. Metabolomics, 2013)










ROC curve with good 
predictive capacity
ROC curve with perfect predictive 
capacity
ROC curve without 
predictive capacity




























• not meet the stratification criteria
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ASSIGNATION IDENTIFICATION NC vs PB NC vs PI PB vs PI
0.88 188.0049 [M – H]- 2-Aminophenol sulphate ↑ ↑ –
1.48 328.1036 [M + H]+ HPAA glucuronide ↑ ↑ –
326.0851 [M – H]- – ↑ –
2.07 168.0609 [M + H]+ HHPAA – ↑ ↑
3.40 372.0925 [M + H]+ HMBOA glucuronide ↑ – –
370.0772 [M – H]- ↑ ↑ –
3.68 326.0922 [M – H]- HBOA glycoside – ↑ ↑
3.72 152.0671 [M + H]+ HPPA – ↑ –
4.78 196.0596 [M + H]+ HMBOA ↑ ↑ –
194.0410 [M – H]- ↑ ↑ –
2.85 357.0791 [M – H]- DHPPA glucuronide ↑ ↑ ↑
3.12 233.0118 [M – H]- 3,5-Dihydroxyphenylethanol sulphate – ↑ –
5.75 289.0412 [M – H]- DHPPTA sulphate – ↑ ↑
3.67 313.0558 [M – H]- Hydroxybenzoic acid glucuronide ↑ ↑ –
4.72 275.0219 [M – H]- Dihydroferulic acid sulphate – ↑ ↑
6.32 299.1278 [M + H – GlcA]+ Enterolactone glucuronide – ↑ ↑
473.1447 [M – H]- – ↑ ↑
2.73 255.1345 [M + H]+ Pyrraline – ↑ –
253.1172 [M – H]- – ↑ ↑
3.25 338.0871 [M + H]+ 3-Indolecarboxylic acid glucuronide – ↑ ↑
336.0697 [M – H]- – ↑ ↑
4.65 377.1475 [M + H]+ Riboflavine ↑ ↑ ↑
0.63 218.1140 [M + H]+ N-α-Acetylcitrulline – ↓ –
4.20 338.0882 [M + H]+ 2,8-Dihydroxyquinoline glucuronide – ↑ ↑
160.0382 [M – H – GlcA]- – ↑ ↑
(Garcia-Aloy M et al. Metabolomics, 2015)
vs vs vs
HPAA glucuronide 73.5% (63.8%-83.2%) 64.0% (53.3%-74.6%)
HHPAA 67.8% (57.7%-77.9%) 69.7% (59.3%-80.1%)
HMBOA glucuronide 68.2% (57.8%-78.7%)
HPPA 69.9% (59.8%-79.9%)
HMBOA 68.4% (57.8%-79.0%) 66.3% (55.6%-77.0%)
Enterolactone glucuronide 69.6% (59.7%-79.5%) 73.0% (63.0%-83.1%)
Pyrraline 65.8% (55.6%-76.0%)
3-Indolecarboxylic acid glucuronide 67.2% (57.0%-77.4%) 65.5% (54.6%-76.5%)
Riboflavin 64.2% (53.4%-75.0%) 73.2% (63.7%-82.8%) 62.9% (51.5%-74.4%)
2-Aminophenol sulphate 66.4% (56.0%-76.7%) 68.9% (59.0%-78.9%)
HPAA glucuronide 62.0% (51.7%-72.4%)
HMBOA glucuronide 66.1% (55.9%-76.3%) 61.0% (50.5%-71.5%)
HBOA glycoside 73.0% (63.6%-82.4%) 63.4% (52.6%-74.2%)
HMBOA 69.2% (59.2%-79.3%) 66.8% (56.8%-76.7%)
DHPPA glucuronide 64.9% (54.4%-75.4%) 78.4% (69.8%-87.1%) 65.1% (54.5%-75.8%)
3,5-Dihidroxifeniletanol sulphate 67.0% (56.8%-77.2%)
DHPPTA sulphate 76.7% (67.6%-85.7%) 76.1% (67.1%-85.1%)
Hydroxybenzoic acid glucuronide 67.4% (57.2%-77.6%) 61.3% (50.8%-71.7%)
Dihydroferulic acid sulphate 74.3% (65.0%-83.6%) 74.6% (65.0%-84.2%)
Enterolactone glucuronide 65.6% (55.4%-75.7%) 62.8% (52.2%-73.4%)
Pyrraline 64.8% (54.7%-75.0%) 62.5% (51.6%-73.3%)
3-Indolecarboxylic acid glucuronide 66.8% (56.9%-76.7%) 63.0% (52.3%-73.7%)
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Coef. Err. Est. p








Riboflavin 0,842 0,340 0,013
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(Garcia-Aloy M et al. Metabolomics, 2015)
vs
Coef. Err. Est. p
HPAA glucuronide
HHPAA 1,750 0,787 0,026
HMBOA glucuronide
HPPA 1,361 0,579 0,019
HMBOA 1,362 0,674 0,043
Enterolactone glucuronide 1,642 0,559 0,003
Pyrraline 1,436 0,636 0,024
3-Indolecarboxylic acid glucuronide 1,617 0,556 0,004





HMBOA 1,856 0,659 0,005
DHPPA glucuronide 1,289 0,439 0,003
3,5-Dihidroxifeniletanol sulphate
DHPPTA sulphate 1,685 0,481 <0,001
Hydroxybenzoic acid glucuronide
Dihydroferulic acid sulphate 0,911 0,438 0,037
Enterolactone glucuronide 1,157 0,581 0,047
Pyrraline 1,397 0,502 0,005
3-Indolecarboxylic acid glucuronide 0,980 0,449 0,029
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Coef. Err. Est. p
HPAA glucuronide




Enterolactone glucuronide 2,009 0,500 <0,001










DHPPTA sulphate 1,159 0,327 <0,001
Hydroxybenzoic acid glucuronide
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Metabolites related with 
bread composition




(Garcia-Aloy M et al. Metabolomics, 2015)
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(Tulipani S et al. J Proteome Res, 2011; Garcia-Aloy M et al. J Proteome Res, 2014)
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4.80 257.0085 [M – H]- 10-Hydroxy-decene-4,6-
diynoic acid sulfate177.0545 [M – H – sulfate]-
6.25
385.1844 [M – H]- Tridecadienoic/tridecynoic
acid glucuronide386.1880 13C[M – H]-
387.2011 [M + H]+
211.1688 [M + H – GlcA]+
193.1576 [M + H – GlcA – H2O]
+
6.72 229.1403 [M – H]- Dodecanedioic acid
230.1441 13C[M – H]-
211.1314 [M – H – H2O]
-
167.1433 [M – H – H2O – CO2]
-
2.55 204.9827 [M – H]- Pyrogallol sulfate
233.0118 [HSO3 – H]
-
5.10 325.0890 [M – H]- p-Coumaryl alcohol 
glucuronide326.0987 13C[M – H]-
5.28
403.0627 [M – H]- Urolithin A glucuronide
404.0654 13C[M – H]-
227.0357 [M – H – GlcA]-
405.0817 [M + H]+
229.0495 [M + H – GlcA]+
5.30 483.0195 [M – H]- Urolithin A sulfoglucuronide
6.55 229.0197 [M – H]- p-Coumaryl alcohol sulfate
230.0221 13C[M – H]-
149.0615 [M – H – sulfate]-
150.0646 13C[M – H – sulfate]-
6.75 306.9885 [M – H]- Urolithin A sulfate
4.30 297.0560 [M – H]- N-Acetylserotonin sulfate
4.62 190.0505 [M – H]- Hydroxyindoleacetic acid
146.0614 [M – H – CO2]
-
192.0648 [M + H]+
174.0539 [M + H – H2O]
+








4.62 257.0149 [M – H]-
10-Hydroxy-decene-4,6-diynoic 
acid sulfate
6.20 385.1838 [M – H]- Tridecadienoic/tridecynoic acid 
glucuronide386.1899 13C[M – H]-
387.1995 [M + H]+
388.2035 13C[M + H]+
211.1668 [M + H – GlcA]+
5.22 419.0618 [M – H]- Urolithin C glucuronide
5.25 403.0662 [M – H]- Urolithin A glucuronide
404.0677 13C[M – H]-
227.0398 [M – H – GlcA]-
228.0425 13C[M – H – GlcA]-
405.0830 [M + H]+
422.1100 [M + NH4]
+
229.0490 [M + H – GlcA]+
5.35 483.0227 [M – H]- Urolithin A sulfoglucuronide
6.25 387.0770 [M – H]- Urolithin B glucuronide
211.0381 [M – H – GlcA]-
212.0436 13C[M – H – GlcA]-
389.0864 [M + H]+
213.0534 [M + H – GlcA]+
6.34 473.1491 [M – H]- Enterolactone glucuronide
474.1525 13C[M – H]-
297.1127 [M – H – GlcA]-
492.1842 [M + NH4]
+
6.67 243.0295 [M – H – sulfate]- Urolithin C sulfate
6.72 306.9915 [M – H]- Urolithin A sulfate
227.0348 [M – H – sulfate]-
3.23 336.0751 [M – H]- 3-Indolecarboxylic acid 
glucuronide338.0854 [M + H]+
3.83 270.0081 [M – H]- Hydroxyindoleacetic acid sulfate
4.20 297.0561 [M – H]- N-Acetylserotonin sulfate
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(Tulipani S et al. J Proteome Res, 2011; Garcia-Aloy M et al. J Proteome Res, 2014)
RT m/z ASSIGNATION IDENTIFICATION
5.28
403.0627 [M – H]- Urolithin A 
glucuronide404.0654 13C[M – H]-
227.0357 [M – H – GlcA]-
405.0817 [M + H]+
229.0495 [M + H – GlcA]+
RT m/z ASSIGNATION IDENTIFICATION
5.25 403.0662 [M – H]- Urolithin A 
glucuronide404.0677 13C[M – H]-
227.0398 [M – H – GlcA]-
228.0425 13C[M – H – GlcA]-
405.0830 [M + H]+
422.1100 [M + NH4]
+
229.0490 [M + H – GlcA]+
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10-Hydroxy-decene-4,6-diynoic acid sulfate 74.4% (66.4%-82.5%) 72.6% (65.0%-80.3%)
Tridecadienoic/tridecynoic acid glucuronide 85.1% (79.8%-90.4%) 77.2% (70.4%-84.0%)
Urolithin C glucuronide 75.4% (67.7%-83.0%) 71.4% (63.8%-79.0%)
Urolithin A glucuronide 82.0% (75.7%-88.4%) 83.2% (77.3%-89.1%)
Urolithin A sulfoglucuronide 70.4% (62.0%-78.7%) 79.0% (72.1%-85.9%)
Urolithin B glucuronide 59.1% (50.6%-67.7%) 67.7% (59.6%-75.8%)
Enterolactone glucuronide 62.3% (54.1%-70.5%) 66.3% (58.4%-74.2%)
Urolithin C sulfate 69.7% (61.5%-78.0%) 73.3% (65.7%-80.9%)
Urolithin A sulfate 78.7% (71.3%-86.1%) 79.2% (72.5%-85.9%)
3-Indolecarboxylic acid glucuronide 73.7% (66.2%-81.3%) 60.2% (52.0%-68.4%)
Hydroxyindoleacetic acid sulfate 61.0% (52.5%-69.6%) 68.8% (61.2%-76.3%)
N-Acetylserotonin sulfate 64.5% (56.2%-72.8%) 64.5% (56.5%-72.5%)
(Garcia-Aloy M et al. J Proteome Res, 2014)
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10-Hydroxy-decene-4,6-diynoic acid sulfate 1,041 0,431 0,016
Tridecadienoic/tridecynoic acid glucuronide 2,212 0,491 <0,001
Urolithin C glucuronide





Urolithin A sulfate 0,812 0,395 0,040
3-Indolecarboxylic acid glucuronide 0,945 0,306 0,002
Hydroxyindoleacetic acid sulfate
N-Acetylserotonin sulfate
(Garcia-Aloy M et al. J Proteome Res, 2014)
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(Garcia-Aloy M et al. J Proteome Res, 2014)
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(Llorach R et al. Mol Nutr Food Res, 2013; Garcia-Aloy M et al. Mol Nutr Food Res, 2015)
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0.87 199.0832/197.0691 [M + H]+/[M – H]- AMMU
1.08 183.0493 [M + H]+ 7-Methyluric acid
1.22 199.0844/197.0701 [M + H]+/[M – H]- AMMU isomer
1.68 183.0516 [M + H]+ 3-Methyluric acid
2.05 167.0575 [M + H]+ 7-Metilxanthine
2.47 167.0570/165.0429 [M + H]+/[M – H]- 3-Metilxanthine
2.80 197.0688/195.0526 [M + H]+/[M – H]- 3,7-Dimethyluric acid
3.37 181.0719 [M + H]+ Theobromine
3.67 343.0684 [M – H]- Vanillic acid glucuronide
3.85 226.0711/224.0592 [M + H]+/[M – H]- Vanilloglycine
4.95 465.1071 [M – H]- (Epi)catechin glucuronide
5.15 423.0280 [M – H]- Vanillic acid sulfoglucuronide
5.58 545.0614 [M – H]- (Epi)catechin sulfoglucurónido
6.02 383.0486 [M – H]- Methyl(epi)catechin sulfate
6.32 383.0459 [M – H]- Methyl(epi)catechin sulfate
4.05 401.1112 [M – H]- HDHPVA glucuronide
4.23 401.1090 [M – H]- HDHPVA glucuronide
4.35 223.0972 [M + H]+ MHPV
4.38 415.1270 [M – H]- HHMPVA sulfate
4.87 385.1143/383.0995 [M + H]+/[M – H]- DHPV glucuronide
5.03 397.1165 [M – H]- MHPV glucuronide
5.10 463.0584 [M – H]- DHPV sulfoglucuronide
5.12 289.0365 [M + H]+ DHPV sulfate
5.13 367.1025 [M – H]- HPV glucuronide
5.17 305.0335 [M – H]- HDHPVA sulfate
5.45 397.1127 [M – H]- MHPV glucuronide
5.53 289.0379 [M – H]- DHPV sulfate
5.72 287.0221 [M – H]- DHPV sulfate
6.12 289.0374/287.0188 [M + H]+/[M – H]- DHPV sulfate
6.45 271.0309 [M – H]- HPVA sulfate
6.50 301.0416 [M – H]- MHPV sulfate
7.12 289.0406 [M – H]- DHPVA sulfate
7.17 273.0453 [M – H]- HPVA sulfate
0.62 140.0328 [M + H]+ Hydroxynicotinic acid
2.83 169.0941 [M + H]+ Cyclo(propylalanyl)
3.08 151.1227 [M + H]+ 3,5-Diethyl-2-methylpyrazine
4.67 278.0698 [M – H]- N-[4’-Hydroxycinnamoyl]-L-aspartic acid
5.07 308.0782 [M – H]- N-[4’-Hydroxy-3’-methoxy-cinnamoyl]-aspartic
1.22 262.0359 [M + H]+ Tyrosine sulfate
1.97 232.1547 [M + H]+ Butyrylcarnitine






0.63 151.0259 [M – H]- Xanthine
0.67 199.0816 [M + H]+ AMMU
0.87 199.0785 [M + H]+ AMMU isomer
1.13 183.0509/181.0325 [M + H]+/[M – H]- 3-Methyluric acid
1.37 167.0568 [M + H]+ 7-Metilxanthine
1.62 167.0597/165.0416 [M + H]+/[M – H]- 3-Metilxanthine
1.85 197.0678/195.0500 [M + H]+/[M – H]- 3,7-Dimethyluric acid
2.75 181.0707 [M + H]+ Theobromine
4.38 230.9982 [M – H]- Vanillin sulfate
4.48 465.1013 [M + H]+ (Epi)catechin glucuronide
4.85 167.0365 [M – H]- Vanillic acid
5.37 369.0252 [M – H]- (Epi)catechin sulfate
3.73 401.1072 [M – H]- HDHPVA glucuronide
3.90 415.1237 [M – H]- HHMPVA glucuronide
3.90 223.0925 [M + H]+ MHPV
4.15 287.0229 [M – H – GlcA]- DHPV sulfoglucuronide
4.20 383.1005 [M – H]- DHPV glucuronide
4.30 225.0736 [M – H]- HDHPVA
4.37 305.0291 [M – H]- HDHPVA sulfate
4.42 385.1105/383.0972 [M + H]+/[M – H]- DHPV glucuronide
4.60 319.0495 [M – H]- HHMPVA sulfate
4.60 397.1101 [M – H]- MHPV glucuronide
4.70 367.0990 [M – H]- HPV glucuronide
5.22 289.0343 [M + H]+ DHPV sulfate
5.62 191.0678 [M – H – sulfato]- HPV sulfate
6.54 289.0391 [M – H]- DHPVA sulfate
6.64 273.0454 [M – H]- HPVA sulfate
1.88 170.0449 [M + H]+ Furoylglycine
4.72 261.0872 [M – H]- Cyclo(aspartyl-phenylalanyl)
4.73 281.1135/279.0943 [M + H]+/[M – H]- Aspartyl-Phenylalanine
1.87 290.1590 [M + H]+ Methylglutarylcarnitine
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Untargeted metabolomics approach to obtain a 
metabolic footprint of regular dietary 
consumption by designing models of combined 
urinary biomarkers: Cocoa product intake in free-
living subjects from the PREDIMED study
Mar Garcia-Aloy, Rafael Llorach, Mireia Urpi-Sarda, Olga Jáuregui, Dolores 
Corella, Miguel A. Martínez-González, Jordi Salas-Salvadó, Montserrat Fitó, 
Emilio Ros, Ramon Estruch, Cristina Andres-Lacueva. [submitted]
Acute Intervention Long-term intervention
Free-living population
isomer
(Garcia-Aloy M et al. Mol Nutr Food Res, 2015)
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(Garcia-Aloy M et al. Mol Nutr Food Res, 2015)
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(Garcia-Aloy M et al. Mol Nutr Food Res, 2015)
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(Llorach R et al. Mol Nutr Food Res, 2013; Garcia-Aloy M et al. Mol Nutr Food Res, 2015)
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